BRANDT KEVIN D (VP & Chief Commercial Officer) sold 3.2% of their position (23K shares) of XTANT MEDICAL HOLDINGS, INC. on the open market
Open‑market sale worth $11.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/17/2022ACC: 0001235802-22-000101
Officer· VP & Chief Commercial Officer
Since Jul 2018
+387.08K
Net shares
Net buyer
$11.2K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
410.08K acquired · 23K disposed
Non-Derivative Transactions3
Common Stock, $0.000001 par value
Direct
Shares
+410.08K
Price / share
—
Trade value
—
% of position
129.6%
8/15/2022
316.49K→726.57K
Common Stock, $0.000001 par value
Direct
Shares
−18.70K
Price / share
$0.49
Trade value
$9.17K
% of position
2.6%
8/16/2022
726.57K→707.87K
Common Stock, $0.000001 par value
Direct
Shares
−4.30K
Price / share
$0.48
Trade value
$2.05K
% of position
0.6%
8/17/2022
707.87K→703.57K
Total
Net shares
+387.08K
Net value
-$11.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value Direct | 8/15/2022 | A · Award | +410.08K | — | — | 129.6% | 316.49K | 726.57K |
| Common Stock, $0.000001 par value Direct | 8/16/2022 | S · Sale | −18.70K | $0.49 | $9.17K | 2.6% | 726.57K | 707.87K |
| Common Stock, $0.000001 par value Direct | 8/17/2022 | S · Sale | −4.30K | $0.48 | $2.05K | 0.6% | 707.87K | 703.57K |
| Total | +387.08K | -$11.22K | ||||||
Derivative Transactions0
No derivative transactions reported